AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

THE VACCINE.(search for AIDS vaccine in Africa)

The New Yorker

| February 03, 2003 | Specter, Michael | COPYRIGHT 2003 All rights reserved. Reproduced by permission of The Condé Nast Publications Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

At forty-one, Hala has five children and eight grandchildren. Her first husband left when their second child was born. Her second husband died of AIDS nearly twenty years ago, in the earliest days of the epidemic. Hala often tells people that she sells charcoal, doughnuts, or cooking oil on the streets, but that isn't true. She is a prostitute, who has spent nearly half her life working out of a wattle hut in Pumwani, one of Nairobi's most crowded--and violent--slums. On an average day, she might see ten men, most of them truck drivers from Tanzania. Her "office" has just enough room for a single bed, a stool, a customer, herself, and a wicker basket filled with condoms. The basket is a recent addition; only in the past year or so have her clients agreed to use condoms with any regularity.

None of these details make Hala unusual. Despite the severity of the AIDS epidemic, Kenyans have only just begun to speak openly about the disease, and the epidemic has certainly done little to deter prostitution. As many as two and a half million people in Kenya, one in six adults, are infected with H.I.V. In Pumwani, more than ninety per cent of prostitutes--and many of their clients--test positive for the virus. Hala has engaged in unprotected sex with hundreds of H.I.V-positive men. Her best customer--a man who visited her regularly for seventeen years, and never used a condom--recently died of AIDS. Remarkably, though, she has never become infected.

The day I was introduced to Hala, at a clinic not far from where she lives, she was draped in black robes and wore a purple shawl with gold piping down the sides. She is a handsome, businesslike woman, and she is completely baffled by her fate. "I have no idea why I of all people have been spared,'' she told me. "But if my luck can be useful to the doctors then I will be grateful."

Hala belongs to an increasingly famous cohort of research subjects, known by AIDS experts throughout the world as "the Nairobi prostitutes.'' In the late nineteen-eighties, the Canadian infectious-disease expert Francis Plummer noticed something startling: in a study of two thousand Nairobi prostitutes, as many as two hundred remained uninfected, despite years of constant high-risk behavior. Later, when Plummer and his colleagues examined the data more closely, they realized that if the prostitutes didn't become infected within five years of their first exposure to the virus, they were unlikely to become infected at all.

How, exactly, were these women protected when millions who engaged in the same behavior fell ill and died? It couldn't have been luck; nobody gets lucky a thousand times in a row. Nor was it good nutrition; the women often lived on plantains and rice, and many were weak, undernourished, and sickly. Plummer concluded that these women harbored a rare defensive weapon within their immune systems. To many vaccine researchers, the implications were thrilling: if they could identify that weapon and somehow bottle it, they might help to end the world's most devastating epidemic. "We all held our breath for a while,'' Job J. Bwayo, the director of the International AIDS Vaccine Initiative in Kenya, told me when I went to see him at the University of Nairobi. "Nobody expected a simple solution to come from it, but we have all kept hoping that somehow the girls will provide the key."

The search for a solution has become desperate. Twenty-one years after the first cases of "slim disease," as AIDS was initially called in Africa, appeared in a Ugandan village on the shores of Lake Victoria, scientists are only marginally closer to producing a successful vaccine than they were when they identified the virus that causes it. A great deal has changed for people with AIDS in those two decades: medicines are now routinely available throughout the developed world. But, of the forty million people who are living with H.I.V., less than five per cent have access to them. Because that percentage will not change dramatically in the next decade, the world has never needed a medical intervention more urgently than it needs an AIDS vaccine today.

Thanks in part to a United Nations special session devoted to AIDS, the plight of Africa has finally gained at least a measure of attention. Last fall, I watched at a clinic in Nairobi as a farmworker received a new kind of H.I.V. test, one that provides almost instant results. A nurse took a few drops of his blood, the man sat quietly on a bench for half an hour, and then he had his answer. Even a year ago, this man, and tens of thousands like him, would have had to make a second journey to the clinic--often on foot--to get the test results; many would not have been able, or willing, to do that. While I was in Nairobi, I attended a support group for infected mothers, visited well-maintained clinics in the most fetid slums, and was surprised to see billboards on the main highway urging precautions. After years of denial, even politicians acknowledge that AIDS poses a serious threat to the future of the nation. In Uganda, where President Yoweri Museveni long ago established himself as the African leader most willing to speak openly about the disease, the epidemic has ebbed. In each of the past ten years, there have been fewer new H.I.V. infections than in the year before, a feat managed by no other African country. Although six per cent of the adults in Uganda remain infected--a toll that would be horrifying almost anywhere else on earth--the figure a decade ago was more than twenty per cent.

Related articles from newspapers, magazines, journals, and more
South Africa Approves IAVI Sponsored AIDS Vaccine Candidate for Human Trials.
Press release article from: PR Newswire August 25, 2003 700+ words
...trial of a preventive AIDS vaccine candidate under study...nonprofit International AIDS Vaccine Initiative (IAVI...by the University of Nairobi in Kenya and University...the second preventive AIDS vaccine candidate that the MCC...
Ugandan Government and International AIDS Vaccine Initiative Sign Agreement to...
Press release article from: PR Newswire August 30, 2001 700+ words
...PRNewswire/ -- The International AIDS Vaccine Initiative (IAVI) and the...was the site of the first AIDS vaccine trial in Africa. We are proud...researchers from the University of Nairobi in Kenya and have been tested...be carried out in a special AIDS Vaccine Trial Unit which ...
G-8 Summit: Call for Leaders to Deliver on Commitments To Speed AIDS Vaccine...
Press release article from: PR Newswire July 20, 2001 700+ words
...info@iavi.org About AIDS Vaccine Development Prospects...first human trials of an AIDS vaccine developed for Africa...and the University of Nairobi in Kenya, is now fully...IAVI The International AIDS Vaccine Initiative is an international...
IAVI Hails Start of AIDS Vaccine Testing in South Africa.
Press release article from: PR Newswire November 3, 2003 700+ words
...with the South African AIDS Vaccine Initiative. The trial...different preventive AIDS vaccine candidate is anticipated...IAVI, the University of Nairobi, the University of Oxford...By testing multiple AIDS vaccine candidates at once...
HEALTH: AIDS VACCINE MAY TAKE DECADES TO DEVELOP, EXPERTS SAY.
News wire article from: Interpress Service August 8, 2008 700+ words
...expectations regarding an imminent AIDS vaccine and powerful vaginal microbicides...founder of the International AIDS Vaccine Initiative, speaking at the...professor at the University of Nairobi School of Medicine, said...also director of the Kenya AIDS Vaccine Initiative. "We ...
IAVI Begins AIDS Vaccine Trials in South Africa, Switzerland.
Press release article from: PR Newswire November 12, 2003 700+ words
...Research Council in Durban. AIDS vaccine research in South Africa is coordinated by the South African AIDS Vaccine Initiative. In Switzerland...including the University of Nairobi and the Kenya AIDS Vaccine Initiative; the Uganda Virus...
IAVI Hails Start of Trial in South Africa and U.S. to Test AlphaVax's AIDS...
Press release article from: PR Newswire July 30, 2003 700+ words
...AlphaVax's AVX101 AIDS vaccine candidate has been shown...Two other preventive AIDS vaccine candidates are poised...IAVI, the University of Nairobi in Kenya and the University...quickly to discover an AIDS vaccine, never compromising...
IAVI Outlines New, Intensive R&D Agenda to Fast-Track Promising AIDS Vaccine...
Press release article from: PR Newswire July 9, 2002 700+ words
...challenges still impeding AIDS vaccine development, including...tracking an IAVI-sponsored AIDS vaccine candidate, named DNA...Oxford and University of Nairobi, into Phase III trials...resources are directed at AIDS vaccine development," said...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA